Amoxicillin
Mycobacterium Abscessus Infection
The University of QueenslandSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 81/ 100
Competitive context
19 Active assets in the Mycobacterium Abscessus Infection cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
BACILLUS CALMETTE-GUERIN STRAIN TICE LIVE ANTIGEN Johns Hopkins University | Phase 2 | B |
Thalidomide National Center for Research Resources (NCRR) | Phase 2 | B |
CEFOXITIN The University of Queensland | Phase 2 | CCC |
RIFABUTIN The University of Queensland | Phase 2 | CCC |
Tigecycline The University of Queensland | Phase 2 | CCC |
View all 21 →
Same molecule, other indications
Amoxicillin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →